Phaseline

Targets › CNSR1

CNSR1: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Neurology.

Open in Phaseline: the race on CNSR1, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Eastern Virginia Medical SchoolTHC-free CBD Oil
Cannabidiol receptor agonist
CNSR1, CNSR2Phase 2Alzheimer Disease–

Conditions

Alzheimer Disease (1)

Modalities

small molecule (1)

Companies

Eastern Virginia Medical School (1)

Related targets

CNSR2 (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.